Biomedical Engineering Reference
In-Depth Information
9. Bernstein FC, Koetzle TF, Williams GJ, Meyer EF Jr, Brice MD, Rodgers JR et al (1978) The
Protein Data Bank: a computer-based archival file for macromolecular structures. Arch
Biochem Biophys 185(2):584-591
10. Bertini I, Calderone V, Fragai M, Luchinat C, Mangani S, Terni B (2004) Crystal structure of
the catalytic domain of human matrix metalloproteinase 10. J Mol Biol 336(3):707-716
11. Betz M, Huxley P, Davies SJ, Mushtaq Y, Pieper M, Tschesche H et al (1997) 18-A crystal
structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8)
complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectiv-
ity profile. Eur J Biochem 247(1):356-363
12. Bittar EE, Bittar N (1995) Cellular organelles and the extracellular matrix. JAI Press,
Greenwich, CT
13. Black LD, Allen PG, Morris SM, Stone PJ, Suki B (2008) Mechanical and failure properties
of extracellular matrix sheets as a function of structural protein composition. Biophys J
94(5):1916-1929
14. Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP et al (2005) Potent
pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14. Bioorg
Med Chem Lett 15(7):1807-1810
15. Bosman FT, Stamenkovic I (2003) Functional structure and composition of the extracellular
matrix. J Pathol 200(4):423-428
16. Butler GS, Tam EM, Overall CM (2004) The canonical methionine 392 of matrix metallopro-
teinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity: probing
the role of the methionine-turn in the metzincin metalloprotease superfamily. J Biol Chem
279(15):15615-15620
17. Carrascal N, Rizzo RC (2009) Calculation of binding free energies for non-zinc chelating
pyrimidine dicarboxamide inhibitors with MMP-13. Bioorg Med Chem Lett 19(1):47-50
18. Chakrabarti B, Bairagya HR, Mallik P, Mukhopadhyay BP, Bera AK (2011) An insight to
conserved water molecular dynamics of catalytic and structural Zn(+2) ions in matrix metal-
loproteinase 13 of human. J Biomol Struct Dyn 28(4):503-516
19. Clark IM, Young DA, Rowan AD (2010) Matrix metalloproteinase protocols, 2nd edn.
Humana, New York, NY
20. Conant K, Gottschall PE (2005) Matrix metalloproteinases in the central nervous system.
Imperial College Press, London, Hackensack, NJ, Distributed by World Scientific
21. Cornwell KG, Landsman A, James KS (2009) Extracellular matrix biomaterials for soft tissue
repair. Clin Podiatr Med Surg 26(4):507-523
22. Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-
derived cells contributes to skin carcinogenesis. Cell 103(3):481-490
23. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI (2004) Matrix metallo-
proteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis
colorectal cancers. Clin Cancer Res 10(24):8229-8234
24. Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis.
J Pathol 189(3):300-308
25. Damsky CH, Werb Z (1992) Signal transduction by integrin receptors for extracellular matrix:
cooperative processing of extracellular information. Curr Opin Cell Biol 4(5):772-781
26. Diaz N, Suarez D (2007) Molecular dynamics simulations of matrix metalloproteinase 2: role
of the structural metal ions. Biochemistry 46(31):8943-8952
27. Diaz N, Suarez D (2008) Molecular dynamics simulations of the active matrix metalloprotei-
nase-2: positioning of the N-terminal fragment and binding of a small peptide substrate.
Proteins 72(1):50-61
28. Eck SM, Hoopes PJ, Petrella BL, Coon CI, Brinckerhoff CE (2009) Matrix metalloprotei-
nase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast
Cancer Res Treat 116(1):79-90
29. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer
progression. Nat Rev Cancer 2(3):161-174
Search WWH ::
Custom Search